tiprankstipranks
Luye Pharma Group Reports Strong Mid-Year Financials
Company Announcements

Luye Pharma Group Reports Strong Mid-Year Financials

Luye Pharma Group (HK:2186) has released an update.

Invest with Confidence:

Luye Pharma Group Ltd. has reported a robust increase in its financial performance for the first half of 2024, with a 5.9% growth in revenue to RMB 3.07 billion and an impressive 201.4% surge in net profit to RMB 438.2 million compared to the same period last year. The earnings per share also saw a substantial rise to RMB 10.31 cents. Despite these strong results, the company has decided not to propose an interim dividend.

For further insights into HK:2186 stock, check out TipRanks’ Stock Analysis page.

Related Articles
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App

Latest News Feed

More Articles